Press releases

2024-09-30 15:40 Prolight Diagnostics publishes investor letter for september 2024

2024-09-26 08:30 Prolight showcases Psyros™ to global key opinion leaders in cardiology at 2024 Cardiac Markers Dialogue Meeting Regulatory

2024-09-25 14:30 Prolight conducts business review at FlexMedical Solutions

2024-08-30 13:48 Emergers publishes an updated analysis on Prolight Diagnostics, reaffirming a justified value of 1.1-1.2 SEK per share

2024-08-28 08:00 Prolight Diagnostics publishes half-year report, 2024 Regulatory MAR

2024-07-03 08:00 Prolight Diagnostics presents the Psyros system at ADLM, one of the world's largest and most important diagnostics congresses Regulatory

2024-06-04 08:35 Warrants of series TO6 were exercised to approximately 44.8 percent and Prolight Diagnostics receives approximately SEK 9.8 million Regulatory MAR

2024-05-29 08:00 Prolight has obtained subscription commitments for exercising warrants of series TO6 from, among others, members of the Board and management of approximately SEK 1.0 million Regulatory

2024-05-28 08:00 Last day of trading with warrants of series TO6 in Prolight Diagnostics is today, May 28, 2024 Regulatory

2024-05-27 20:35 Annual general meeting of Prolight Diagnostics AB (publ) on 27 May 2024 Regulatory

Subscribe